PMID- 23971168
OWN - NLM
STAT- MEDLINE
DCOM- 20131112
LR  - 20191112
IS  - 1780-2393 (Print)
IS  - 1780-2393 (Linking)
VI  - 96
IP  - 3
DP  - 2013 May-Jun
TI  - Whole body PET-CT: M staging in non small-cell lung cancer.
PG  - 127-31
AB  - FDG PET has been used for years in the diagnosis and recurrence of non small cell 
      lung cancer (NSCLC). It has an important impact on patient management, and its 
      coupling with CT for immediate fusion allows immediate localization and 
      characterization of uptake. This article reviews the role of FDG PET-CT in the 
      staging of NSCLC for the detection of metastatic disease.
FAU - Hanin, F X
AU  - Hanin FX
AD  - Nuclear Medicine Department, Cliniques Universitaires Saint-Luc, Brussels, 
      Belgium.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Belgium
TA  - JBR-BTR
JT  - JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de 
      Koninklijke Belgische Vereniging voor Radiologie (KBVR)
JID - 100888280
SB  - IM
MH  - Carcinoma, Non-Small-Cell Lung/*pathology/*secondary
MH  - Humans
MH  - Lung Neoplasms/*pathology
MH  - Lymphatic Metastasis
MH  - Mediastinum/pathology
MH  - Multimodal Imaging/*methods
MH  - Neoplasm Staging
MH  - *Positron-Emission Tomography
MH  - *Tomography, X-Ray Computed
MH  - Whole Body Imaging/*methods
EDAT- 2013/08/27 06:00
MHDA- 2013/11/13 06:00
CRDT- 2013/08/27 06:00
PHST- 2013/08/27 06:00 [entrez]
PHST- 2013/08/27 06:00 [pubmed]
PHST- 2013/11/13 06:00 [medline]
AID - 10.5334/jbr-btr.233 [doi]
PST - ppublish
SO  - JBR-BTR. 2013 May-Jun;96(3):127-31. doi: 10.5334/jbr-btr.233.